Dose-volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 4, 2012, Pages

  Chen, Ronald C ^a,b,c   Mamon, Harvey J ^c   Ancukiewicz, Marek ^a   Killoran, Joseph H ^c   Crowley, Elizabeth M ^a   Blaszkowsky, Lawrence S ^a   Wo, Jennifer Y ^a   Ryan, David P ^a   Hong, Theodore S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chemoradiation therapy; Dose volume histogram; Patient reported outcomes; Quality of life; Rectal cancer

Indexed keywords

CHEMORADIATION; DOSE-VOLUME HISTOGRAMS; PATIENT-REPORTED OUTCOMES; QUALITY OF LIFE; RECTAL CANCER;

CHEMORADIOTHERAPY; DISEASES; DOSIMETERS; DOSIMETRY; HOSPITALS; PATIENT MONITORING;

TOXICITY;

CAPECITABINE; FLUOROURACIL;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; DEFECATION URGENCY; DIARRHEA; DOSE RESPONSE; DOSIMETRY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LARGE INTESTINE; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RECTUM CANCER; SMALL INTESTINE; TENESMUS; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY; DEFECATION; DEOXYCYTIDINE; DIARRHEA; FEMALE; FLUOROURACIL; GASTROINTESTINAL DISEASES; HUMANS; INTESTINE, LARGE; INTESTINE, SMALL; MALE; MASSACHUSETTS; MIDDLE AGED; PAIN; QUALITY OF LIFE; RECTAL NEOPLASMS;

EID: 84862705514     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.01.013     Document Type: Article

References (16)

1. Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med 2010;362:865-869.
2. Clauser SB, Ganz PA, Lipscomb J, et al. Patient-reported outcomes assessment in cancer trials: Evaluating and enhancing the payoff to decision making. J Clin Oncol 2007;25:5049-5050.
3. Sauer R, Fietkau R, Wittekind C, et al. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer: A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol 2001;177:173-181.
4. Bosset J, Calais G, Daban A, et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: Assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 2004;40:219-224.
5. Miller R, Martenson J, Sargent D, et al. Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma. Int J Radiat Oncol Biol Phys 1998;41:593-598.
6. Chen R, Mamon H, Chen Y, et al. Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer. Cancer 2010;116:1879-1886.
7. Baglan K, Frazier R, Yan D, et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2002;52:176-183.
8. Robertson J, Söhn M, Yan D. Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model. Int J Radiat Oncol Biol Phys 2010;77:66-72.
9. Clark J, Talcott J. Symptom indexes to assess outcomes of treatment for early prostate cancer. Med Care 2001;39:1118-1130.
10. Lipscomb J, Gotay C, Snyder C. Patient-reported outcomes in cancer: A review of recent research and policy initiatives. CA Cancer J Clin 2007;57:278-300.
11. Guren MG, Dueland S, Skovlund E, et al. Quality of life during radiotherapy for rectal cancer. Eur J Cancer 2003;39:587-594.
12. Gunnlaugsson A, Kjellén E, Nilsson P, et al. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer. Acta Oncol 2007;46:937-944.
13. Nguyen PL, Chen RC, Hoffman KE, et al. Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: A subgroup analysis of a randomized trial. Int J Radiat Oncol Biol Phys 2010;78:1081-1085.
14. Tho L, Glegg M, Paterson J, et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: Investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 2006;66:505-513.
15. Bratland A, Dueland S, Hollywood D, et al. Gastrointestinal toxicity of vorinostat: Reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy. Radiat Oncol 2011;6:33.
16. Kavanagh BD, Pan CC, Dawson LA, et al. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys 2010;76:S101-S107.